dc.contributor.author |
Kimaiyo Sylvester |
|
dc.contributor.author |
Siika Abraham Mosigisi |
|
dc.date.accessioned |
2019-02-07T13:01:37Z |
|
dc.date.available |
2019-02-07T13:01:37Z |
|
dc.date.issued |
2014-03-14 |
|
dc.identifier.uri |
http://ir.mu.ac.ke:8080/xmlui/handle/123456789/2722 |
|
dc.description.abstract |
Since the beginning of the HIV pandemic, almost 60 million
people have been infected with HIV and 25 million have
died from HIV-associated illnesses [1]. Sub-Saharan Africa
is the region most affected by the pandemic and is home to
68% of all people living with HIV worldwide [1]. Since 2002,
the international drive to scale up antiretroviral treatment
has gained tremendous momentum [2], and by the close
of 2009, an estimated 5.2 million persons were receiving
combination antiretroviral treatment (cART). While this
represents important progress, this still is only about 35% of
the people who are estimated in need of treatment according
to current standards of care |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Hindawi Publishing Corporation AIDS Research and Treatment |
en_US |
dc.subject |
Antiretroviral Therapy |
en_US |
dc.title |
Short-Term Rationing of Combination Antiretroviral Therapy: Impact on Morbidity, Mortality, and Loss to Follow-Up in a Large HIV Treatment Program in Western Kenya |
en_US |
dc.type |
Article |
en_US |